JANNEY DANIEL, a director at Krystal Biotech, Inc. ($KRYS), sold shares on the open market twenty-two times over the last 365 days, totaling $19.4 million. His most recent sale occurred on February 27, 2026. These sales rank 691st among 11,678 individual insiders in our database, surpassing the average sale amount of $8.6 million across 6.4 transactions per insider. JANNEY DANIEL made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 9430 | $275.45 | 75,666.0000 | 29,951,000 | 11.08% | 0.03% |
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 2373 | $276.17 | 73,293.0000 | 29,951,000 | 3.14% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 8986 | $266.18 | 108,146.0000 | 29,951,000 | 7.67% | 0.03% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 3963 | $268.97 | 85,839.0000 | 29,951,000 | 4.41% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 370 | $269.83 | 85,469.0000 | 29,951,000 | 0.43% | 0.00% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 373 | $271.09 | 85,096.0000 | 29,951,000 | 0.44% | 0.00% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 62 | $263.05 | 107,300.0000 | 29,951,000 | 0.06% | 0.00% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 900 | $264.60 | 106,400.0000 | 29,951,000 | 0.84% | 0.00% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 1604 | $265.54 | 104,796.0000 | 29,951,000 | 1.51% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 4339 | $266.62 | 100,457.0000 | 29,951,000 | 4.14% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 1891 | $267.37 | 98,566.0000 | 29,951,000 | 1.88% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 1674 | $268.67 | 96,892.0000 | 29,951,000 | 1.70% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 930 | $269.50 | 95,962.0000 | 29,951,000 | 0.96% | 0.00% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 2425 | $274.90 | 93,537.0000 | 29,951,000 | 2.53% | 0.01% |
| Feb. 25, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 700 | $275.00 | 92,837.0000 | 29,951,000 | 0.75% | 0.00% |
| Feb. 26, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 5103 | $275.28 | 87,734.0000 | 29,951,000 | 5.50% | 0.02% |
| Feb. 26, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 2638 | $276.32 | 85,096.0000 | 29,951,000 | 3.01% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | M | Stock Option (Right to Buy) | 37895 | $0.00 | 0.0000 | 29,951,000 | 100.00% | 0.13% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | M | Common Stock | 37895 | $2.46 | 122,991.0000 | 29,951,000 | 44.53% | 0.13% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 569 | $262.91 | 122,422.0000 | 29,951,000 | 0.46% | 0.00% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 1733 | $264.12 | 120,689.0000 | 29,951,000 | 1.42% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 3557 | $265.08 | 117,132.0000 | 29,951,000 | 2.95% | 0.01% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 11673 | $266.97 | 96,473.0000 | 29,951,000 | 10.79% | 0.04% |
| Feb. 24, 2026 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 6671 | $268.04 | 89,802.0000 | 29,951,000 | 6.91% | 0.02% |
| June 30, 2025 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 29,740,000 | 9999.99% | 0.02% |
| June 30, 2024 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 27,752,000 | 9999.99% | 0.02% |
| June 30, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | A | Stock Option (Right to Buy) | 6800 | $0.00 | 6,800.0000 | 25,492,000 | 9999.99% | 0.03% |
| June 8, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 5000 | $127.96 | 141,297.0000 | 25,492,000 | 3.42% | 0.02% |
| June 8, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 10000 | $127.96 | 131,297.0000 | 25,492,000 | 7.08% | 0.04% |
| June 8, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 5000 | $127.86 | 126,297.0000 | 25,492,000 | 3.81% | 0.02% |
| June 9, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 3935 | $129.29 | 122,362.0000 | 25,492,000 | 3.12% | 0.02% |
| June 8, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 4604 | $127.96 | 152,758.0000 | 25,492,000 | 2.93% | 0.02% |
| June 9, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 10000 | $128.53 | 107,362.0000 | 25,492,000 | 8.52% | 0.04% |
| June 9, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 5000 | $128.84 | 117,362.0000 | 25,492,000 | 4.09% | 0.02% |
| June 8, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 1073 | $129.02 | 151,685.0000 | 25,492,000 | 0.70% | 0.00% |
| June 8, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 5388 | $128.73 | 146,297.0000 | 25,492,000 | 3.55% | 0.02% |
| May 19, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 50000 | $95.02 | 157,362.0000 | 25,492,000 | 24.11% | 0.20% |
| May 9, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 17100 | $90.74 | 207,362.0000 | 25,492,000 | 7.62% | 0.07% |
| April 19, 2023 | Krystal Biotech, Inc. | $KRYS | JANNEY DANIEL | Director | S | Common Stock | 7900 | $90.32 | 224,462.0000 | 25,492,000 | 3.40% | 0.03% |